Stocks
MapLight Therapeutics, Inc.MPLT
NASDAQHealthcareBiotechnology$7.97
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company focused on developing small molecule therapeutics for central nervous system disorders. Its lead candidates target conditions such as Parkinson's disease and schizophrenia, with a pipeline that investors track for clinical trial readouts and regulatory milestones.
52W Range: $7.46-$40.43
Congressional Interest in MapLight Therapeutics, Inc. (MPLT)
No congressional trades have been disclosed for MapLight Therapeutics, Inc. (MPLT) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading MPLT?
No congressional trades found for this stock.